Imperagen Founders to Present in IBIC Webinar Series

Imperagen’s co-founders, Dr. Andrew Currin (Chief Scientific Officer) and Tim Eyes (Chief Product Officer), will be presenting in an upcoming session of the Industrial Biotechnology Innovation Catalyst (IBIC) webinar series.

In this session, they will share how Imperagen is harnessing the power of AI and laboratory automation to transform enzyme engineering for industrial biotechnology applications. The discussion will explore how our Digital Enzyme Evolution™ platform is helping to accelerate innovation and solve real-world challenges across the sector.

Andrew and Tim will also reflect on their journey building Imperagen—from academic roots to a cutting-edge TechBio company—offering personal insights into the challenges, milestones, and key lessons along the way.

This is a valuable opportunity to gain a deeper understanding of the technologies shaping the future of enzyme development, and to hear directly from two of the leading voices in UK biotech.